Eaton Vance Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $47.8M | Sell |
1,189,393
-36,612
| -3% | -$1.47M | 0.07% | 271 |
|
|
2022
Q2 | $51.5M | Buy |
1,226,005
+110,957
| +10% | +$4.66M | 0.07% | 258 |
|
|
2022
Q1 | $43.4M | Buy |
1,115,048
+106,698
| +11% | +$4.16M | 0.05% | 338 |
|
|
2021
Q4 | $40.2M | Buy |
1,008,350
+12,482
| +1% | +$497K | 0.05% | 338 |
|
|
2021
Q3 | $36.1M | Sell |
995,868
-387,205
| -28% | -$14M | 0.05% | 324 |
|
|
2021
Q2 | $56.7M | Buy |
1,383,073
+374,100
| +37% | +$15.3M | 0.08% | 243 |
|
|
2021
Q1 | $44M | Buy |
1,008,973
+146,833
| +17% | +$6.4M | 0.07% | 289 |
|
|
2020
Q4 | $43.2M | Buy |
862,140
+308,143
| +56% | +$15.4M | 0.07% | 266 |
|
|
2020
Q3 | $23.3M | Buy |
553,997
+112,146
| +25% | +$4.72M | 0.04% | 335 |
|
|
2020
Q2 | $21.5M | Buy |
+441,851
| New | +$21.5M | 0.04% | 327 |
|